Patents for A61P 33 - Antiparasitic agents (21,787)
03/2001
03/07/2001CN1286258A Purine L-nucleoside, analogs and use thereof
03/07/2001CN1062861C Triazine derivs., production and use thereof
03/07/2001CN1062763C Medicine for treating gastric cancer and preparation method thereof
03/06/2001US6197815 Animal feed additive by preparing metal amino acid chelates, increasing desired metal uptake by the animal, and concomitant growth facilitation and enhancement for the treated animals.
03/06/2001US6197745 Methods for producing nitrosated hemoglobins and therapeutic uses therefor
03/06/2001US6197301 Compositions and methods for the prevention and diagnosis of Lyme disease
03/01/2001WO2001014557A1 Pd-1, a receptor for b7-4, and uses therefor
03/01/2001WO2001014536A2 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence
03/01/2001WO2001014341A1 Agents for controlling animal diseases caused by parasites
03/01/2001WO2001014340A1 Agents for controlling animal diseases caused by endoparasites
03/01/2001WO2001013954A1 Method of treating body insect infestation
03/01/2001WO2001013944A2 Stress-proteins from extra-cellular pathogens as vaccines against infectious agents
03/01/2001WO2001013942A2 Trehalose producing prokaryotic cells as vaccines
03/01/2001WO2001013920A1 Carnitine analogues as topical, microbicidal spermicides
03/01/2001WO2001013913A1 Compositions containing esters for treating parasitic infestations of organisms
03/01/2001CA2383456A1 Pd-1, a receptor for b7-4, and uses therefor
02/2001
02/28/2001EP1078631A1 Use of macrolide antibiotics for the treatment or prevention of coccidiosis
02/28/2001EP1077994A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
02/28/2001EP1077974A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors
02/28/2001EP1077971A1 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
02/28/2001EP1077713A1 Stable oil-in-glycerin emulsion
02/28/2001EP1077708A1 Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides
02/28/2001CN1285841A Novel erythromycin derivatives
02/27/2001US6194425 Viricides, antitumor agents
02/27/2001US6194421 Parasiticides
02/27/2001US6194408 Parasiticides
02/27/2001US6194401 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of α-glycerophosphoric acid
02/27/2001US6194388 Immunomodulatory oligonucleotides
02/27/2001CA2316647A1 Treatment or prevention of coccidiosis
02/22/2001WO2001012229A1 Pharmaceutical compositions for oral and topical administration
02/22/2001WO2001012181A1 Improved topical medicaments and methods for photodynamic treatment of disease
02/22/2001WO2001012156A1 Topical organic ectoparasiticidal formulations
02/22/2001WO2001012155A1 Compositions and methods for enhanced absorption of hydrophilic therapeutic agents
02/22/2001WO2001011964A1 Ectoparasiticidal aqueous suspension formulations of spinosyns
02/22/2001WO2001011963A1 Oral treatment of companion animals with ectoparasiticidal spinosyns
02/22/2001WO2000078941A3 Methods and products for manipulating uncoupling protein expression
02/22/2001WO2000055126A3 N-cyanomethylamides as protease inhibitors
02/22/2001DE19939578A1 New nucleic acid encoding hemocyanin, useful for gene therapy of tumors and for recombinant production of fusion proteins for vaccination
02/22/2001CA2452118A1 Pharmaceutical compositions for oral and topical administration
02/22/2001CA2380643A1 Topical organic ectoparasiticidal formulations
02/22/2001CA2380642A1 Compositions and methods for enhanced absorption of hydrophilic therapeutic agents
02/21/2001CN1284995A Tissue cement proteins from rhipicephalus appendiculatus
02/21/2001CN1284957A Imidazonaphthyridines and their use in inducing cytokine biosynthesis
02/21/2001CN1284885A Vaccine
02/21/2001CN1284884A 疫苗 Vaccine
02/20/2001US6191270 Nucleotide sequences coding plasmodium protein; for prevention and immunization against plasmodium infection
02/15/2001WO2001010847A2 Novel integrin receptor antagonists
02/15/2001WO2001010468A2 Drug-carrier complexes and methods of use thereof
02/15/2001WO2001010383A2 Caspase inhibitors and uses thereof
02/15/2001WO2000061184A3 Dry formulation for transcutaneous immunization
02/15/2001WO2000059483A3 Transdermal drug delivery devices comprising a polyurethane drug reservoir
02/15/2001DE19936780A1 Neue Antagonisten von Integrinrezeptoren New antagonists of integrin
02/15/2001CA2379977A1 Novel integrin receptor antagonists
02/14/2001EP1076057A1 Febrifugine and isofebrifugine and processes for the preparation of both
02/14/2001EP1075493A2 Dna encoding snorf25 receptor
02/14/2001EP1075483A2 Hygromycin a derivatives
02/14/2001CN1284081A Novel macrolides compounds
02/14/2001CN1283990A Long cating injectable formulations contg. hydrogenated castor oil
02/14/2001CN1283461A Antiparasitic pre-mixture containing evericin, ivermection or acetylamino evericin for fish, shrimp and crab
02/14/2001CN1283458A Compound dihydroartemisinin as new antimalarial
02/13/2001US6187944 A phenyl acrylonitrile compounds useful as active ingredients of an insecticide, a miticide, a nematicide, a soil pesticide, a fungicide and a marine antifouling agent
02/13/2001US6187310 Recombinant Entamoeba histolytica lectin subunit peptides and reagents specific for members of the 170 kDa subunit multigene family
02/13/2001CA2021788C Cyclosporin derivatives
02/08/2001WO2001009341A2 Method of determining the activity of 1-deoxy-d-xylulose-5-phosphate reductoisomerase and 1-deoxy-d-xylulose-5-phosphate synthase
02/08/2001WO2001009186A2 Therapeutic compounds comprised of anti-fc receptor binding agents
02/08/2001WO2001009184A1 Human g-protein coupled receptor
02/08/2001WO2001009155A1 Cloning of the streptomyces avermitilis genes for glycosylation of avermectin aglycones
02/08/2001WO2001009088A1 Urea derivatives as inhibitors of ccr-3 receptor
02/08/2001WO2000061772A3 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
02/08/2001CA2381565A1 Therapeutic compounds comprised of anti-fc receptor binding agents
02/08/2001CA2380639A1 Cloning of the <i>streptomyces avermitilis</i> genes for glycosylation of avermectin aglycones
02/08/2001CA2379360A1 Human g-protein coupled receptor
02/07/2001EP1074263A2 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoylate saturated hydroxy-fatty acid
02/07/2001EP1073741A2 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides
02/07/2001EP1073710A2 Non-stochastic generation of genetic vaccines and enzymes
02/07/2001CN1283111A Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis
02/06/2001CA2213798C Method for stimulating an immune response
02/01/2001WO2001007651A2 Transposon mediated differential hybridisation
02/01/2001WO2001007628A2 Human synthetases
02/01/2001WO2001007612A2 Receptors and associated proteins
02/01/2001WO2001007471A2 Cell cycle and proliferation proteins
02/01/2001WO2001007087A2 Enzyme catalyzed anti-infective therapeutic agents
02/01/2001WO2001007042A1 Apicidin-derived cyclic tetrapeptides
02/01/2001WO2001007035A1 Use of tosylchloramide(s) for treating diseases of the skin, mucous membranes, organs and tissues
02/01/2001WO1998034604A8 ANTI-PARASITIC ACTION OF N,N-DIETHYL-m-TOLUAMIDE (DEET) AND FORMULATIONS THAT PROLONG ITS ACTIVITY IN THE SKIN
02/01/2001CA2380317A1 Human synthetases
02/01/2001CA2380171A1 Transposon mediated differential hybridisation
02/01/2001CA2379834A1 Enzyme catalyzed anti-infective therapeutic agents
02/01/2001CA2379801A1 Receptors and associated proteins
02/01/2001CA2379784A1 Cell cycle and proliferation proteins
02/01/2001CA2378849A1 Apicidin-derived cyclic tetrapeptides
01/2001
01/31/2001EP1071959A2 Method for identifying chemical active agents and active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway
01/31/2001EP1071708A1 Edg family gene, human h218
01/31/2001EP1071452A1 Vaccine compositions comprising cd-1 antigens and t-cell stimulating compound and methods of use thereof
01/31/2001EP1071409A2 Use of organophosphoric compounds for the therapeutic and preventative treatment of infections
01/31/2001EP1071407A1 Lipophilic microparticles containing a protein drug or antigen and formulation comprising same
01/31/2001CN1061351C Intermediates diaza or oxadiazabicyclic compounds
01/31/2001CN1061213C Method for combating fish parasites
01/30/2001US6180676 Guanylhydrazones and their use to treat inflammatory conditions
01/30/2001US6180604 Compositions and methods for treating infections using analogues of indolicidin